137 related articles for article (PubMed ID: 37916327)
1. Weighted gene co-expression network analysis of key targets and interventional mechanism of Milkvetch root in diabetic nephropathy.
Zeng SN; Li Y; Li YM; Wang SR
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(20):9614-9627. PubMed ID: 37916327
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of diabetic nephropathy expression profile based on weighted gene co-expression network analysis algorithm.
Gholaminejad A; Fathalipour M; Roointan A
BMC Nephrol; 2021 Jul; 22(1):245. PubMed ID: 34215202
[TBL] [Abstract][Full Text] [Related]
3. Application of weighted gene co-expression network analysis to identify novel key genes in diabetic nephropathy.
Wang Z; Chen X; Li C; Tang W
J Diabetes Investig; 2022 Jan; 13(1):112-124. PubMed ID: 34245661
[TBL] [Abstract][Full Text] [Related]
4. Identification of PDK4 as Hub Gene for Diabetic Nephropathy Using Co-Expression Network Analysis.
Han Y; Jin L; Wang L; Wei L; Tu C
Kidney Blood Press Res; 2023; 48(1):522-534. PubMed ID: 37385224
[TBL] [Abstract][Full Text] [Related]
5. Single-cell RNA and transcriptome sequencing profiles identify immune-associated key genes in the development of diabetic kidney disease.
Zhang X; Chao P; Zhang L; Xu L; Cui X; Wang S; Wusiman M; Jiang H; Lu C
Front Immunol; 2023; 14():1030198. PubMed ID: 37063851
[TBL] [Abstract][Full Text] [Related]
6. RNA-Seq Analysis of ceRNA-Related Networks in the Regulatory Metabolic Pathway of Mice with Diabetic Nephropathy Subjected to Empagliflozin Intervention.
Wu T; Zhang Z; Huang H; Wu X
Arch Esp Urol; 2023 Nov; 76(9):680-689. PubMed ID: 38053423
[TBL] [Abstract][Full Text] [Related]
7. Diabetic kidney disease-predisposing proinflammatory and profibrotic genes identified by weighted gene co-expression network analysis (WGCNA).
Chen J; Luo SF; Yuan X; Wang M; Yu HJ; Zhang Z; Yang YY
J Cell Biochem; 2022 Feb; 123(2):481-492. PubMed ID: 34908186
[TBL] [Abstract][Full Text] [Related]
8. Network pharmacology-based identification of miRNA expression of Astragalus membranaceus in the treatment of diabetic nephropathy.
Dai Y; Guo M; Jiang L; Gao J
Medicine (Baltimore); 2022 Feb; 101(5):e28747. PubMed ID: 35119030
[TBL] [Abstract][Full Text] [Related]
9. Co-expression modules construction by WGCNA and identify potential hub genes and regulation pathways of postpartum depression.
Deng Z; Cai W; Liu J; Deng A; Yang Y; Tu J; Yuan C; Xiao H; Gao W
Front Biosci (Landmark Ed); 2021 Nov; 26(11):1019-1030. PubMed ID: 34856750
[No Abstract] [Full Text] [Related]
10. Revealing the underlying mechanism of diabetic nephropathy viewed by microarray analysis.
Qu W; Han C; Li M; Zhang J; Li L
Exp Clin Endocrinol Diabetes; 2015 Jun; 123(6):353-9. PubMed ID: 25918880
[TBL] [Abstract][Full Text] [Related]
11. Identification of potential crosstalk genes and mechanisms between periodontitis and diabetic nephropathy through bioinformatic analysis.
Lu H; Sun J; Sun J
Medicine (Baltimore); 2023 Dec; 102(52):e36802. PubMed ID: 38206700
[TBL] [Abstract][Full Text] [Related]
12. Construction of a TF-miRNA-mRNA Regulatory Network for Diabetic Nephropathy.
Dong F; Zheng L; Yang G
Arch Esp Urol; 2024 Jan; 77(1):104-112. PubMed ID: 38374020
[TBL] [Abstract][Full Text] [Related]
13. Seven basement membrane-specific expressed genes are considered potential biomarkers for the diagnosis and treatment of diabetic nephropathy.
Gui H; Chen X; Ye L; Ma H
Acta Diabetol; 2023 Apr; 60(4):493-505. PubMed ID: 36627452
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics prediction and experimental verification of key biomarkers for diabetic kidney disease based on transcriptome sequencing in mice.
Zhao J; He K; Du H; Wei G; Wen Y; Wang J; Zhou X; Wang J
PeerJ; 2022; 10():e13932. PubMed ID: 36157062
[TBL] [Abstract][Full Text] [Related]
15. Identification of Lumican and Fibromodulin as Hub Genes Associated with Accumulation of Extracellular Matrix in Diabetic Nephropathy.
Feng S; Gao Y; Yin D; Lv L; Wen Y; Li Z; Wang B; Wu M; Liu B
Kidney Blood Press Res; 2021; 46(3):275-285. PubMed ID: 33887734
[TBL] [Abstract][Full Text] [Related]
16. Identifying C1QB, ITGAM, and ITGB2 as potential diagnostic candidate genes for diabetic nephropathy using bioinformatics analysis.
Hu Y; Yu Y; Dong H; Jiang W
PeerJ; 2023; 11():e15437. PubMed ID: 37250717
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatics Analysis of the Mechanisms of Diabetic Nephropathy
Guo M; Dai Y; Jiang L; Gao J
Front Endocrinol (Lausanne); 2022; 13():934022. PubMed ID: 35909518
[TBL] [Abstract][Full Text] [Related]
18. Identification of Hub Genes Involved in Tubulointerstitial Injury in Diabetic Nephropathy by Bioinformatics Analysis and Experiment Verification.
Yang J; Peng L; Tian Y; Tang W; Peng L; Ning J; Li D; Peng Y
J Immunol Res; 2022; 2022():7907708. PubMed ID: 35991124
[TBL] [Abstract][Full Text] [Related]
19. Identification of miRNAs-genes regulatory network in diabetic nephropathy based on bioinformatics analysis.
Yang F; Cui Z; Deng H; Wang Y; Chen Y; Li H; Yuan L
Medicine (Baltimore); 2019 Jul; 98(27):e16225. PubMed ID: 31277135
[TBL] [Abstract][Full Text] [Related]
20. Identification of key genes and biological regulatory mechanisms in diabetic nephropathy: Meta-analysis of gene expression datasets.
Hojjati F; Roointan A; Gholaminejad A; Eshraghi Y; Gheisari Y
Nefrologia (Engl Ed); 2023; 43(5):575-586. PubMed ID: 36681521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
